Determining class I human leukocyte antigens (HLA) on specimens for those patients who have become refractory to platelet transfusions and identify potential disease associations or markers for drug hypersensitivity
FENTU - Overview: Fentanyl with Metabolite Confirmation, Random, Urine
Detection and confirmation of illicit drug use involving fentanyl
GATOL - Overview: Galactitol, Quantitative, Urine
Monitoring effectiveness of treatment in patients with galactosemia Establishing a baseline level prior to initiating treatment for galactosemia
BUPM - Overview: Buprenorphine and Norbuprenorphine, Random, Urine
Monitoring of compliance utilizing buprenorphine Detection and confirmation of the illicit use of buprenorphine
DIPGS - Overview: Diphtheria Toxoid IgG Antibody, Serum
Determining a patient's immunological response to diphtheria toxoid vaccination Aiding in the evaluation of immunodeficiency
FUNSF - Overview: Fungitell, CSF
Fungitell, CSF
FFT4F - Overview: T4, Free, Direct Dialysis
T4, Free, Direct Dialysis
TGRP - Overview: Testosterone, Total and Free, Serum
Alternative, second-level test for suspected increases or decreases in physiologically active testosterone: -Assessment of androgen status in cases with suspected or known sex hormone-binding globulin-binding abnormalities -Assessment of...
ADEVL - Overview: Alzheimer Disease Evaluation, Spinal Fluid
Assessment of adults with cognitive impairment being evaluated for Alzheimer disease and other causes of cognitive impairment These assays should not be used to predict the development of dementia or other neurologic conditions or to...
PBCPN - Overview: Primary Biliary Cholangitis Antibody Panel, Serum
Evaluation of at-risk or previously diagnosed primary biliary cholangitis patients with new features of other liver diseases or systemic autoimmune diseases
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.